
The Amyl Team wishes you a Merry Christmas and a Happy New Year 2025 !
As 2024 is ending, we want to express our gratitude to our partners, investors, and collaborators. 2024 has been a year of challenges and major changes for us, driving innovation and progress in our research on neurodegenerative diseases.
In 2025, we will push again the boundaries of science, collaborating with passionate experts, and reach our objective of a Pan Amyloid Immunotherapeutic to treat Alzheimer’s disease and other neurodegenerative disorders.
Wishing you all a joyful holiday season and a new year filled with success, health, and hope.
The Amyl Team